Status:
UNKNOWN
Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis
Lead Sponsor:
Yonsei University
Conditions:
Adenomyosis
Eligibility:
FEMALE
19-48 years
Phase:
NA
Brief Summary
The primary purpose of this study is to compare the therapeutic efficacy of intrauterine device and uterine artery embolization for uterine adenomyosis.
Detailed Description
Screening * History, Physical examination * Laboratory test (Hemoglobin) / MRI * Pictorial blood loss assessment chart * Symptom/Quality of life score Intervention * Intrauterine device or uterine ...
Eligibility Criteria
Inclusion
- 1\. Women with symptomatic fibroids (age: 19 - 48 years old) 2. Hemglobin \< 12g/dL, 3. Symptoms of adenomysis (Menorrhagia, Dysmenorrhea)
Exclusion
- 1\. Gynecologic malignancy 2. Ongoing infection or inflammation 3. Coagulopathy (platelet \< 50,000 or INR \> 1.5) 4. Concomitant endometriosis 5. Pregnancy
Key Trial Info
Start Date :
July 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06043583
Start Date
July 21 2023
End Date
July 1 2025
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance hospital
Seoul, South Korea